Iván Sanz Muñoz-rekin lankidetzan egindako argitalpenak (29)

2024

  1. Association of viral loads of influenza A (H3N2) with age and care setting on presentation—a prospective study during the 2022-2023 influenza season in Spain

    International Journal of Infectious Diseases, Vol. 143

  2. Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024

    Eurosurveillance, Vol. 29, Núm. 6

  3. Factors associated to the presence of headache in patients with influenza infection and its consequences: a 2010–2020 surveillance-based study

    Journal of Headache and Pain, Vol. 25, Núm. 1

  4. Impact on the time elapsed since SARS-CoV-2 infection, vaccination history, and number of doses, on protection against reinfection

    Scientific Reports, Vol. 14, Núm. 1

  5. Importancia de los Centros Nacionales de Gripe en la vigilancia de virus aviares de alta patogenicidad. El momento para One-Health es ahora

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 121-126

  6. Incidence and prevalence of headache in influenza: A 2010–2021 surveillance-based study

    European Journal of Neurology

  7. Microbiological and epidemiological features of respiratory syncytial virus

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 3, pp. 209-220

  8. Potential Effects on Elderly People From Nirsevimab Use in Infants

    Open Respiratory Archives, Vol. 6, Núm. 2

2023

  1. Active medical recommendation is the best tool for increasing influenza vaccine coverage in healthy adult workers

    Vacunas, Vol. 24, Núm. 2, pp. 88-94

  2. Adjuvants for COVID-19 Vaccines

    Vaccines, Vol. 11, Núm. 5

  3. An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study

    Frontiers in Immunology, Vol. 14

  4. Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people

    Frontiers in Immunology, Vol. 14

  5. Group 1 and group 2 hemagglutinin stalk antibody response according to age

    Frontiers in Immunology, Vol. 14

  6. Impact of COVID-19 on Adherence to Treatment in Patients with HIV

    Healthcare (Switzerland), Vol. 11, Núm. 9

  7. InfluenCEF study: Clinical phenotype and duration of headache attributed to influenza infection

    Cephalalgia : an international journal of headache, Vol. 43, Núm. 11

  8. Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults

    Human vaccines & immunotherapeutics, Vol. 19, Núm. 2, pp. 2236537

  9. Old and new aspects of influenza

    Medicina Clinica, Vol. 161, Núm. 7, pp. 303-309

  10. The Impact of the COVID-19 Pandemic on Influenza Vaccination Attitudes and Actions in Spain’s Adult Population

    Vaccines, Vol. 11, Núm. 10

2022

  1. Attitudes, Perceptions and Practices of Influenza Vaccination in the Adult Population: Results of a Cross-Sectional Survey in Spain

    International journal of environmental research and public health, Vol. 19, Núm. 17

  2. Coinfections of influenza and other respiratory viruses are associated to children

    Anales de Pediatria, Vol. 96, Núm. 4, pp. 334-341